The following is a list of new features introduced in 20R1.
For each feature, the list includes information on how enablement works and which applications include the feature. You can see detailed explanations for the features below in What’s New in 20R1.
Case Intake
Case Processing
Feature |
Enablement |
Additional Information |
Medical Review Enhancements |
|
- |
Symptom Classification for Adverse Events |
|
Depending on your Vault settings, these fields will appear automatically or may need to be added to page layouts before they appear. Contact your Veeva Services representative for more information. |
Case Level Relatedness and Automatic SUSAR/SAE Detection |
|
The Relatedness filter is available automatically on the Case tab for all users with no additional action required. However, Admins must update page layouts to add the Reporter Assessment Result and Relatedness fields, as well as some other configuration changes. Enable Case Level Relatedness and Automatic SUSAR/SAE Tagging provides instructions. |
Blinded Case Previews |
|
- |
Controlled Vocabulary: Extended Configurability |
|
While this feature is auto-on, to enable status changes to deactivate Controlled Vocabulary records, an administrator must Enable Controlled Vocabulary User Actions |
Case Product Dose and Indication Sections |
|
Enable Case Product Dose and Indication Sections |
Frequency: Multi-Option Control |
|
- |
Uniform Control Enhancements |
|
- |
Precise Naming for Assessment Matrix, Case Product, and Adverse Event |
|
- |
Case Product Drug Role: Treatment |
|
Contact Veeva Services to request configuration upgrades to enable this feature in your Vault |
Coding
Monitoring
Submissions and Distributions
Feature |
Enablement |
Additional Information |
Masked Content Distributions |
|
Enable Masked Distributions |
CIOMS I Form Update and Comprehensive Overflows |
|
While this feature is Auto-on, to leverage the new CIOMS Remarks field, an administrator must add it to the Case Detail Page Layout and grant the following permission sets access to edit this field on the Product object:
- Case Entry Actions
- Case Intake Actions
- Case Review Actions
|
FDA 3500A Comprehensive Overflows |
|
While this feature is Auto-on, to leverage the new National Drug Code field, an administrator must add it to the Product Registration Detail Page Layout and grant the following permission sets access to edit this field on the Product Registration object:
- Case Entry Actions
- Case Intake Actions
- Case Review Actions
|
E2B Notification Links |
|
- |
Integrations
Feature |
Enablement |
Additional Information |
Import Narrative API |
|
- |
Enablement Details
See the following explanations for enablement options:
Enablement |
Description |
Auto-On |
Automatically activated and no configuration is required before using the feature; note that in some cases, a new feature is dependent on another feature that must be enabled or configured. |
Admin Checkbox |
Admins must turn on the feature with an Admin checkbox. Note that some “Auto-On” features have a checkbox setting that hides the feature; these will show “Auto-On.” |
Configuration |
Admins must configure the feature (separately from an Admin checkbox) before it is available to use or is active; for example, an Admin must add document templates before users can create documents from templates. |
Support |
On/off option controlled by Support. |